Circulating mRNA as diagnostic markers
    1.
    发明申请
    Circulating mRNA as diagnostic markers 有权
    循环mRNA作为诊断标记

    公开(公告)号:US20090162842A1

    公开(公告)日:2009-06-25

    申请号:US11807258

    申请日:2007-05-24

    IPC分类号: C12Q1/68

    摘要: Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclampsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.

    摘要翻译: 提供方法和试剂盒,用于诊断,监测或预测孕妇的先兆子痫,胎儿染色体非整倍性和早产儿的状况,以及孕妇检测怀孕情况,通过定量测量母体血液 编码人绒毛膜促性腺激素β亚基(hCG-β),人胎盘乳腺癌(hPL),促皮质激素释放激素(hCRH),KiSS-1转移抑制因子(KISS1),组织因子途径抑制剂2 (TPFI2),胎盘特异性1(PLAC1)或甘油醛-3-磷酸脱氢酶(GAPDH),并将mRNA种类的量与标准对照进行比较。

    Circulating mRNA as diagnostic markers
    5.
    发明授权
    Circulating mRNA as diagnostic markers 有权
    循环mRNA作为诊断标记

    公开(公告)号:US07829285B2

    公开(公告)日:2010-11-09

    申请号:US11807258

    申请日:2007-05-24

    摘要: Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclampsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.

    摘要翻译: 提供方法和试剂盒,用于诊断,监测或预测孕妇的先兆子痫,胎儿染色体非整倍性和早产儿的状况,以及孕妇检测怀孕情况,通过定量测量母体血液 编码人绒毛膜促性腺激素的一种或多种mRNA种类的量; 亚单位(hCG-和bgr),人胎盘乳腺癌(hPL),促皮质激素释放激素(hCRH),KiSS-1转移抑制因子(KISS1),组织因子途径抑制剂2(TPFI2),胎盘特异性1(PLAC1) 或甘油醛-3-磷酸脱氢酶(GAPDH),并将mRNA种类的量与标准对照进行比较。

    Circulating mRNA as diagnostic markers
    6.
    发明申请
    Circulating mRNA as diagnostic markers 审中-公开
    循环mRNA作为诊断标记

    公开(公告)号:US20080153090A1

    公开(公告)日:2008-06-26

    申请号:US11807253

    申请日:2007-05-24

    IPC分类号: C12Q1/68

    摘要: Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclaimpsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.

    摘要翻译: 提供方法和试剂盒,用于诊断,监测或预测怀孕妇女的pre-eclaimpsia,胎儿染色体非整倍性和早产儿的状况,以及通过定量测量孕妇血液中的孕妇检测怀孕情况 编码人绒毛膜促性腺激素β亚基(hCG-β),人胎盘乳腺癌(hPL),促皮质激素释放激素(hCRH),KiSS-1转移抑制因子(KISS1),组织因子途径抑制剂2 (TPFI2),胎盘特异性1(PLAC1)或甘油醛-3-磷酸脱氢酶(GAPDH),并将mRNA种类的量与标准对照进行比较。

    Method for diagnosing preeclampsia by detecting hCRH mRNA
    7.
    发明授权
    Method for diagnosing preeclampsia by detecting hCRH mRNA 有权
    通过检测hCRH mRNA诊断先兆子痫的方法

    公开(公告)号:US07235359B2

    公开(公告)日:2007-06-26

    申请号:US10759783

    申请日:2004-01-16

    摘要: Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclaimpsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.

    摘要翻译: 提供方法和试剂盒,用于诊断,监测或预测怀孕妇女的pre-eclaimpsia,胎儿染色体非整倍性和早产儿的状况,以及通过定量测量孕妇血液中的孕妇检测怀孕情况 编码人绒毛膜促性腺激素β亚基(hCG-β),人胎盘乳腺癌(hPL),促皮质激素释放激素(hCRH),KiSS-1转移抑制因子(KISS1),组织因子途径抑制剂2 (TPFI2),胎盘特异性1(PLAC1)或甘油醛-3-磷酸脱氢酶(GAPDH),并将mRNA种类的量与标准对照进行比较。

    NONINVASIVE PRENATAL GENOTYPING OF FETAL SEX CHROMOSOMES
    8.
    发明申请
    NONINVASIVE PRENATAL GENOTYPING OF FETAL SEX CHROMOSOMES 审中-公开
    阴性染色体的非侵入性预测基因

    公开(公告)号:US20140019064A1

    公开(公告)日:2014-01-16

    申请号:US13978358

    申请日:2012-01-05

    IPC分类号: G06F19/18

    摘要: Methods, apparatuses, and system are provided for analyzing a maternal sample to determine whether a male fetus of a pregnant female has inherited an X-linked mutation from the mother. A percentage of fetal DNA in the sample is obtained, and cutoff values for the two possibilities (fetus inherits mutant or normal allele) are determined. A proportion of mutant alleles relative to a normal allele on the X-chromosome can then be compared to the cutoff values to make a classification of which allele is inherited. Alternatively, a number of alleles from a target region on the X-chromosome can be compared to a number of alleles from a reference region on the X-chromosome to identify a deletion or amplification. The fetal DNA percentage can be computed by counting reactions with a fetal-specific allele, and correcting the number to account for a statistical distribution among the reactions.

    摘要翻译: 提供方法,装置和系统用于分析母体样品以确定怀孕女性的雄性胎儿是否从母亲遗传了X连锁突变。 获得样品中胎儿DNA的百分比,确定两种可能性(胎儿遗传突变体或正常等位基因)的临界值。 然后将相对于X染色体上的正常等位基因的突变体等位基因的一部分与截断值进行比较,以对哪个等位基因进行遗传分类。 或者,可以将来自X染色体上的目标区域的多个等位基因与来自X染色体上的参考区域的多个等位基因进行比较以鉴定缺失或扩增。 胎儿DNA百分比可以通过计数与胎儿特异性等位基因的反应来计算,并且校正数量以解释反应之间的统计分布。

    Noninvasive prenatal genotyping of fetal sex chromosomes

    公开(公告)号:US10152568B2

    公开(公告)日:2018-12-11

    申请号:US13978358

    申请日:2012-01-05

    IPC分类号: G06F19/18 C12Q1/6883

    摘要: Methods, apparatuses, and system are provided for analyzing a maternal sample to determine whether a male fetus of a pregnant female has inherited an X-linked mutation from the mother. A percentage of fetal DNA in the sample is obtained, and cutoff values for the two possibilities (fetus inherits mutant or normal allele) are determined. A proportion of mutant alleles relative to a normal allele on the X-chromosome can then be compared to the cutoff values to make a classification of which allele is inherited. Alternatively, a number of alleles from a target region on the X-chromosome can be compared to a number of alleles from a reference region on the X-chromosome to identify a deletion or amplification. The fetal DNA percentage can be computed by counting reactions with a fetal-specific allele, and correcting the number to account for a statistical distribution among the reactions.